Table 4.
Univariate and multivariate logistic regression comparing benign/CIN1–2 group and CIN3+ group
| Variable | Univariate | Multivariate HPV | Multivariate Screening | Multivariate Demographics | Multivariate Final | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| HPV-16 | 1.54 | 0.82 – 2.89 | 1.12 | 0.59 – 2.13 | 1.01 | 0.51 – 2.02 | ||||
| HPV-18 | 0.09 ** | 0.01 – 0.63 | 0.09 ** | 0.01 – 0.67 | 0.08 ** | 0.01 – 0.65 | ||||
| HPV-HR Other | 1.46 | 0.78 – 2.72 | ||||||||
| Prior Pap ASCUS or HSIL | 1.29 | 0.67 – 2.52 | 1.67 | 0.79 – 3.58 | 1.28 | 0.56 – 2.91 | ||||
| Prior Procedure | ||||||||||
| Colposcopy | 0.58 | 0.20 – 1.69 | 0.42 | 0.13 – 1.36 | 0.49 | 0.15 – 1.66 | ||||
| LEEP/CKC | 0.83 | 0.28 – 2.48 | 0.65 | 0.20 – 2.06 | 0.65 | 0.19 – 2.19 | ||||
| Prior Screening Adequate | 0.87 | 0.48 – 1.54 | 0.90 | 0.50 – 1.62 | 0.81 | 0.43 – 1.56 | ||||
| Age | 0.99 | 0.96 – 1.03 | 0.99 | 0.96 – 1.02 | 0.99 | 0.96 – 1.02 | ||||
| Race | ||||||||||
| Black | 0.38 | 0.05 – 2.91 | 0.27 | 0.03 – 2.35 | 0.30 | 0.03 – 2.86 | ||||
| Hispanic | 0.34 | 0.04 – 2.60 | 0.28 | 0.04 – 2.23 | 0.32 | 0.04 – 2.67 | ||||
| Other | 1.57 | 0.43 – 5.75 | 1.86 | 0.47 – 7.26 | 1.84 | 0.44 – 7.78 | ||||
| Medicaid/Medicare | 0.82 | 0.35 – 1.94 | 1.01 | 0.40 – 2.52 | 1.00 | 0.38 – 2.61 | ||||
| BMI | 1.03 | 0.99 – 1.07 | 1.04 * | 1.00 – 1.09 | 1.05 * | 1.00 – 1.10 | ||||
| Parity ≥1 | 2.16 ** | 1.08 – 4.33 | 2.38 ** | 1.16 – 4.89 | 2.23 ** | 1.06 – 4.68 | ||||
| Smoking | 0.45 | 0.13 – 1.52 | 0.46 | 0.13 – 1.59 | 0.50 | 0.14 – 1.79 | ||||